P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS
Abstract BACKGROUND After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydroge...
Gespeichert in:
Veröffentlicht in: | Neuro-oncology (Charlottesville, Va.) Va.), 2023-09, Vol.25 (Supplement_2), p.ii36-ii37 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | ii37 |
---|---|
container_issue | Supplement_2 |
container_start_page | ii36 |
container_title | Neuro-oncology (Charlottesville, Va.) |
container_volume | 25 |
creator | Yamashita, S Takeshima, H Kadota, Y Azuma, M Fukushima, T Watanabe, T Yokogami, K |
description | Abstract
BACKGROUND
After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutations and chromosome 1p/19q non-codeletion (IDH mut-Noncodel) with high specificity. Although all institutions could use T2-FLAIR mismatch sign without any obstacles, this sign was not completely helpful because of its low sensitivity. In this study, we attempted to uncover the mechanism of T2-FLAIR mismatch sign for clarifying the cause of this sign’s low sensitivity.
MATERIAL AND METHODS
In this study, data on 101 consecutive and unselected patients with LGGs (WHO grades 2 and 3) admitted to Miyazaki University Hospital between November 2005 and January 2021 were collected. The inclusion criteria were as follows: (1) obtained molecular information on IDH mutation and chromosome 1p/19q codeletion status and (2) obtained preoperative MRI data, including T2-weighted imaging and FLAIR sequences. In this study, 99 patients were enrolled and then classified into three groups based on IDH mutation and chromosome 1p/19q codeletion status: (1) IDH-mutant, 1p/19q-codeleted LGGs (IDH mut-codel); (2) IDH-mutant, 1p/19q-noncodeleted LGGs (IDH mut-Noncodel); and (3) IDH wild-type LGGs (IDH wt).
RESULTS
Among 99 patients with LGGs, 22 were T2-FLAIR mismatch sign-positive (22%), and this sign as a marker of IDH mut-Noncodel showed a sensitivity of 55.6% and specificity of 96.8%. Via pathological analyses, we could provide evidence that not only microcystic changes but the enlarged intercellular space was associated with T2-FLAIR mismatch sign (p =0.017). As per the molecular analyses, overexpression of mTOR-related genes (m-TOR, RICTOR) were detected as the molecular events correlated with T2-FLAIR mismatch sign (p = 0.020, 0.030. respectively).
CONCLUSION
We suggested that T2-FLAIR mismatch sign could pick up the IDH mut-Noncodel LGGs with enlarged intercellular space or that with overexpression of mTOR-related genes. |
doi_str_mv | 10.1093/neuonc/noad137.114 |
format | Article |
fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10489531</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noad137.114</oup_id><sourcerecordid>10.1093/neuonc/noad137.114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2304-8342c796cc3a72cfac25ae9a727b9f6d4f0ab67043e183b0c8f42a5416611a6a3</originalsourceid><addsrcrecordid>eNqNkc1Kw0AUhYMoWKsv4GpeYNr5SSaJGxmSaTqQJiVJLa6G6TTRSpuUxAq-gk9taovgTrhwD9zznbs4lnWP0Qgjn47r8tDUZlw3eo2pO8LYvrAG2CEUOh5jlz-aQM_B7rV103VvCBHsMDywvuaIjvrhoCBwEi9kCHlRiGTBCxECmTyJLJdpAjIRpL1-BjOZz3gRTEEuo6Q3gDhdigxGGQ8FiGKZznj-AII0y0TMiyO6lMUUzHkxTeM0kgGPAU9CMEtjESxinoGJTEKZRPmtdVXpbVfenffQWkxE_wmeMWgIRTb0qE2M6zNjqHaJqbQhji79Xrsrv2Jru0J6xVxk0xJ7dIWMV9lEOzZmDGPNNB1aj6fc_WG1K9emrN9bvVX7drPT7adq9Eb9vdSbV_XSfCiMbM93KO4TyCnBtE3XtWX1C2Okjn2oUx_q3Ifq--gheIKaw_4__m9_pYaz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yamashita, S ; Takeshima, H ; Kadota, Y ; Azuma, M ; Fukushima, T ; Watanabe, T ; Yokogami, K</creator><creatorcontrib>Yamashita, S ; Takeshima, H ; Kadota, Y ; Azuma, M ; Fukushima, T ; Watanabe, T ; Yokogami, K</creatorcontrib><description>Abstract
BACKGROUND
After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutations and chromosome 1p/19q non-codeletion (IDH mut-Noncodel) with high specificity. Although all institutions could use T2-FLAIR mismatch sign without any obstacles, this sign was not completely helpful because of its low sensitivity. In this study, we attempted to uncover the mechanism of T2-FLAIR mismatch sign for clarifying the cause of this sign’s low sensitivity.
MATERIAL AND METHODS
In this study, data on 101 consecutive and unselected patients with LGGs (WHO grades 2 and 3) admitted to Miyazaki University Hospital between November 2005 and January 2021 were collected. The inclusion criteria were as follows: (1) obtained molecular information on IDH mutation and chromosome 1p/19q codeletion status and (2) obtained preoperative MRI data, including T2-weighted imaging and FLAIR sequences. In this study, 99 patients were enrolled and then classified into three groups based on IDH mutation and chromosome 1p/19q codeletion status: (1) IDH-mutant, 1p/19q-codeleted LGGs (IDH mut-codel); (2) IDH-mutant, 1p/19q-noncodeleted LGGs (IDH mut-Noncodel); and (3) IDH wild-type LGGs (IDH wt).
RESULTS
Among 99 patients with LGGs, 22 were T2-FLAIR mismatch sign-positive (22%), and this sign as a marker of IDH mut-Noncodel showed a sensitivity of 55.6% and specificity of 96.8%. Via pathological analyses, we could provide evidence that not only microcystic changes but the enlarged intercellular space was associated with T2-FLAIR mismatch sign (p =0.017). As per the molecular analyses, overexpression of mTOR-related genes (m-TOR, RICTOR) were detected as the molecular events correlated with T2-FLAIR mismatch sign (p = 0.020, 0.030. respectively).
CONCLUSION
We suggested that T2-FLAIR mismatch sign could pick up the IDH mut-Noncodel LGGs with enlarged intercellular space or that with overexpression of mTOR-related genes.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noad137.114</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>POSTER PRESENTATIONS</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii36-ii37</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2304-8342c796cc3a72cfac25ae9a727b9f6d4f0ab67043e183b0c8f42a5416611a6a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489531/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489531/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Yamashita, S</creatorcontrib><creatorcontrib>Takeshima, H</creatorcontrib><creatorcontrib>Kadota, Y</creatorcontrib><creatorcontrib>Azuma, M</creatorcontrib><creatorcontrib>Fukushima, T</creatorcontrib><creatorcontrib>Watanabe, T</creatorcontrib><creatorcontrib>Yokogami, K</creatorcontrib><title>P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>Abstract
BACKGROUND
After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutations and chromosome 1p/19q non-codeletion (IDH mut-Noncodel) with high specificity. Although all institutions could use T2-FLAIR mismatch sign without any obstacles, this sign was not completely helpful because of its low sensitivity. In this study, we attempted to uncover the mechanism of T2-FLAIR mismatch sign for clarifying the cause of this sign’s low sensitivity.
MATERIAL AND METHODS
In this study, data on 101 consecutive and unselected patients with LGGs (WHO grades 2 and 3) admitted to Miyazaki University Hospital between November 2005 and January 2021 were collected. The inclusion criteria were as follows: (1) obtained molecular information on IDH mutation and chromosome 1p/19q codeletion status and (2) obtained preoperative MRI data, including T2-weighted imaging and FLAIR sequences. In this study, 99 patients were enrolled and then classified into three groups based on IDH mutation and chromosome 1p/19q codeletion status: (1) IDH-mutant, 1p/19q-codeleted LGGs (IDH mut-codel); (2) IDH-mutant, 1p/19q-noncodeleted LGGs (IDH mut-Noncodel); and (3) IDH wild-type LGGs (IDH wt).
RESULTS
Among 99 patients with LGGs, 22 were T2-FLAIR mismatch sign-positive (22%), and this sign as a marker of IDH mut-Noncodel showed a sensitivity of 55.6% and specificity of 96.8%. Via pathological analyses, we could provide evidence that not only microcystic changes but the enlarged intercellular space was associated with T2-FLAIR mismatch sign (p =0.017). As per the molecular analyses, overexpression of mTOR-related genes (m-TOR, RICTOR) were detected as the molecular events correlated with T2-FLAIR mismatch sign (p = 0.020, 0.030. respectively).
CONCLUSION
We suggested that T2-FLAIR mismatch sign could pick up the IDH mut-Noncodel LGGs with enlarged intercellular space or that with overexpression of mTOR-related genes.</description><subject>POSTER PRESENTATIONS</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNkc1Kw0AUhYMoWKsv4GpeYNr5SSaJGxmSaTqQJiVJLa6G6TTRSpuUxAq-gk9taovgTrhwD9zznbs4lnWP0Qgjn47r8tDUZlw3eo2pO8LYvrAG2CEUOh5jlz-aQM_B7rV103VvCBHsMDywvuaIjvrhoCBwEi9kCHlRiGTBCxECmTyJLJdpAjIRpL1-BjOZz3gRTEEuo6Q3gDhdigxGGQ8FiGKZznj-AII0y0TMiyO6lMUUzHkxTeM0kgGPAU9CMEtjESxinoGJTEKZRPmtdVXpbVfenffQWkxE_wmeMWgIRTb0qE2M6zNjqHaJqbQhji79Xrsrv2Jru0J6xVxk0xJ7dIWMV9lEOzZmDGPNNB1aj6fc_WG1K9emrN9bvVX7drPT7adq9Eb9vdSbV_XSfCiMbM93KO4TyCnBtE3XtWX1C2Okjn2oUx_q3Ifq--gheIKaw_4__m9_pYaz</recordid><startdate>20230908</startdate><enddate>20230908</enddate><creator>Yamashita, S</creator><creator>Takeshima, H</creator><creator>Kadota, Y</creator><creator>Azuma, M</creator><creator>Fukushima, T</creator><creator>Watanabe, T</creator><creator>Yokogami, K</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230908</creationdate><title>P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS</title><author>Yamashita, S ; Takeshima, H ; Kadota, Y ; Azuma, M ; Fukushima, T ; Watanabe, T ; Yokogami, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2304-8342c796cc3a72cfac25ae9a727b9f6d4f0ab67043e183b0c8f42a5416611a6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>POSTER PRESENTATIONS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamashita, S</creatorcontrib><creatorcontrib>Takeshima, H</creatorcontrib><creatorcontrib>Kadota, Y</creatorcontrib><creatorcontrib>Azuma, M</creatorcontrib><creatorcontrib>Fukushima, T</creatorcontrib><creatorcontrib>Watanabe, T</creatorcontrib><creatorcontrib>Yokogami, K</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamashita, S</au><au>Takeshima, H</au><au>Kadota, Y</au><au>Azuma, M</au><au>Fukushima, T</au><au>Watanabe, T</au><au>Yokogami, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2023-09-08</date><risdate>2023</risdate><volume>25</volume><issue>Supplement_2</issue><spage>ii36</spage><epage>ii37</epage><pages>ii36-ii37</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Abstract
BACKGROUND
After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutations and chromosome 1p/19q non-codeletion (IDH mut-Noncodel) with high specificity. Although all institutions could use T2-FLAIR mismatch sign without any obstacles, this sign was not completely helpful because of its low sensitivity. In this study, we attempted to uncover the mechanism of T2-FLAIR mismatch sign for clarifying the cause of this sign’s low sensitivity.
MATERIAL AND METHODS
In this study, data on 101 consecutive and unselected patients with LGGs (WHO grades 2 and 3) admitted to Miyazaki University Hospital between November 2005 and January 2021 were collected. The inclusion criteria were as follows: (1) obtained molecular information on IDH mutation and chromosome 1p/19q codeletion status and (2) obtained preoperative MRI data, including T2-weighted imaging and FLAIR sequences. In this study, 99 patients were enrolled and then classified into three groups based on IDH mutation and chromosome 1p/19q codeletion status: (1) IDH-mutant, 1p/19q-codeleted LGGs (IDH mut-codel); (2) IDH-mutant, 1p/19q-noncodeleted LGGs (IDH mut-Noncodel); and (3) IDH wild-type LGGs (IDH wt).
RESULTS
Among 99 patients with LGGs, 22 were T2-FLAIR mismatch sign-positive (22%), and this sign as a marker of IDH mut-Noncodel showed a sensitivity of 55.6% and specificity of 96.8%. Via pathological analyses, we could provide evidence that not only microcystic changes but the enlarged intercellular space was associated with T2-FLAIR mismatch sign (p =0.017). As per the molecular analyses, overexpression of mTOR-related genes (m-TOR, RICTOR) were detected as the molecular events correlated with T2-FLAIR mismatch sign (p = 0.020, 0.030. respectively).
CONCLUSION
We suggested that T2-FLAIR mismatch sign could pick up the IDH mut-Noncodel LGGs with enlarged intercellular space or that with overexpression of mTOR-related genes.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/noad137.114</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1522-8517 |
ispartof | Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii36-ii37 |
issn | 1522-8517 1523-5866 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10489531 |
source | Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | POSTER PRESENTATIONS |
title | P03.03.A T2-FLUID-ATTENUATED INVERSION RECOVERY MISMATCH SIGN IN LOWER-GRADE GLIOMAS: CORRELATION WITH PATHOLOGICAL AND MOLECULAR FINDINGS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T07%3A34%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P03.03.A%20T2-FLUID-ATTENUATED%20INVERSION%20RECOVERY%20MISMATCH%20SIGN%20IN%20LOWER-GRADE%20GLIOMAS:%20CORRELATION%20WITH%20PATHOLOGICAL%20AND%20MOLECULAR%20FINDINGS&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Yamashita,%20S&rft.date=2023-09-08&rft.volume=25&rft.issue=Supplement_2&rft.spage=ii36&rft.epage=ii37&rft.pages=ii36-ii37&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noad137.114&rft_dat=%3Coup_pubme%3E10.1093/neuonc/noad137.114%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/neuonc/noad137.114&rfr_iscdi=true |